122 related articles for article (PubMed ID: 31442656)
1. High Serum sCD40L Levels During the First Week of Malignant Middle Cerebral Artery Infarction and Mortality.
Lorente L; Martín MM; González-Rivero AF; Sabatel R; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Alvarez-Castillo A; Jiménez A; Borreguero-León JM; García-Marín V
World Neurosurg; 2019 Dec; 132():e630-e636. PubMed ID: 31442656
[TBL] [Abstract][Full Text] [Related]
2. Non-survivor patients with malignant middle cerebral artery infarction showed persistently high serum malondialdehyde levels.
Lorente L; Martín MM; Abreu-González P; Sabatel R; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
BMC Neurol; 2019 Oct; 19(1):238. PubMed ID: 31623565
[TBL] [Abstract][Full Text] [Related]
3. High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients.
Lorente L; Martín MM; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; Borreguero-León JM; González-Rivero AF; Orbe J; Rodríguez JA; Páramo JA
BMC Neurol; 2019 Jul; 19(1):167. PubMed ID: 31319804
[TBL] [Abstract][Full Text] [Related]
4. High serum levels of caspase-cleaved cytokeratin-18 are associated with malignant middle cerebral artery infarction patient mortality.
Lorente L; Martín MM; Pérez-Cejas A; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
BMC Neurol; 2018 Mar; 18(1):32. PubMed ID: 29573748
[TBL] [Abstract][Full Text] [Related]
5. Association between Serum Soluble CD154 Levels and Mortality in Patients with Malignant Middle Cerebral Artery Infarction.
Lorente L; Martín MM; González-Rivero AF; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; Borreguero-León JM
Int J Mol Sci; 2015 May; 16(6):12147-58. PubMed ID: 26030673
[TBL] [Abstract][Full Text] [Related]
6. Nonsurviving Patients with Severe Traumatic Brain Injury Have Maintained High Serum sCD40L Levels.
Lorente L; Martín MM; González-Rivero AF; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; Borreguero-León JM; García-Marín V
World Neurosurg; 2019 Jun; 126():e1537-e1541. PubMed ID: 30926559
[TBL] [Abstract][Full Text] [Related]
7. Serum malondialdehyde levels in patients with malignant middle cerebral artery infarction are associated with mortality.
Lorente L; Martín MM; Abreu-González P; Ramos L; Argueso M; Solé-Violán J; Riaño-Ruiz M; Jiménez A
PLoS One; 2015; 10(5):e0125893. PubMed ID: 25933254
[TBL] [Abstract][Full Text] [Related]
8. High serum substance P levels and mortality after malignant middle cerebral artery infarction.
Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Argueso M; Ramos L; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
J Crit Care; 2020 Jun; 57():1-4. PubMed ID: 31991332
[TBL] [Abstract][Full Text] [Related]
9. Non-survivor septic patients have persistently higher serum sCD40L levels than survivors.
Lorente L; Martín MM; Pérez-Cejas A; Ferreres J; Solé-Violán J; Labarta L; Díaz C; Jiménez A
J Crit Care; 2017 Oct; 41():177-182. PubMed ID: 28570959
[TBL] [Abstract][Full Text] [Related]
10. Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.
Lorente L; Martín MM; Ramos L; Cáceres JJ; Solé-Violán J; Argueso M; Jiménez A; Borreguero-León JM; Orbe J; Rodríguez JA; Páramo JA
BMC Neurol; 2015 Jul; 15():111. PubMed ID: 26162891
[TBL] [Abstract][Full Text] [Related]
11. Serum Levels of B-cell Lymphoma-2 Anti-Apoptotic Protein and Malignant Middle Cerebral Artery Infarction Mortality.
Lorente L; Martín MM; González-Rivero AF; Pérez-Cejas A; Ramos-Gómez L; Solé-Violán J; Cáceres JJ; Villacampa-Jiménez JJ; Jiménez A
J Stroke Cerebrovasc Dis; 2021 May; 30(5):105717. PubMed ID: 33690027
[TBL] [Abstract][Full Text] [Related]
12. Serum Caspase-3 Levels and Early Mortality of Patients with Malignant Middle Cerebral Artery Infarction.
Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Sabatel R; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
Neurocrit Care; 2019 Dec; 31(3):486-493. PubMed ID: 31115825
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble CD40 Ligand levels are associated with severity and mortality of brain trauma injury patients.
Lorente L; Martín MM; González-Rivero AF; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Serrano N; Rodríguez ST; Jiménez A; Borreguero-León JM
Thromb Res; 2014 Oct; 134(4):832-6. PubMed ID: 25123332
[TBL] [Abstract][Full Text] [Related]
14. Serum melatonin levels are associated with mortality in patients with malignant middle cerebral artery infarction.
Lorente L; Martín MM; Abreu-González P; Pérez-Cejas A; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
J Int Med Res; 2018 Aug; 46(8):3268-3277. PubMed ID: 29848129
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble CD40 ligand levels after acute intracerebral hemorrhage.
Lin XF; Ten XL; Tang XB; Chen J
Acta Neurol Scand; 2016 Mar; 133(3):192-201. PubMed ID: 26032911
[TBL] [Abstract][Full Text] [Related]
16. Higher Serum Melatonin Levels during the First Week of Malignant Middle Cerebral Artery Infarction in Non-Surviving Patients.
Lorente L; Martín MM; Abreu-González P; Sabatel R; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
Brain Sci; 2019 Nov; 9(12):. PubMed ID: 31795260
[TBL] [Abstract][Full Text] [Related]
17. Serum Levels of Substance P and Mortality in Patients with a Severe Acute Ischemic Stroke.
Lorente L; Martín MM; Almeida T; Pérez-Cejas A; Ramos L; Argueso M; Riaño-Ruiz M; Solé-Violán J; Hernández M
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338372
[TBL] [Abstract][Full Text] [Related]
18. Association between blood caspase-8 levels and mortality of patients with malignant middle cerebral artery infarction.
Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Ramos-Gómez L; Solé-Violán J; Cáceres JJ; Villacampa-Jiménez JJ; Jiménez A
Med Intensiva (Engl Ed); 2022 Jun; 46(6):305-311. PubMed ID: 35688578
[TBL] [Abstract][Full Text] [Related]
19. Non-Survivor Ischemic Stroke Patients Maintain High Serum Caspase-Cleaved Cytokeratin-18 Levels.
Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Sabatel R; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
Brain Sci; 2020 Feb; 10(3):. PubMed ID: 32120809
[TBL] [Abstract][Full Text] [Related]
20. Persistently higher serum sCD40L levels are associated with outcome in septic patients.
Liang Y; Zhu C; Sun Y; Li Z; Wang L; Liu Y; Li X; Ma X
BMC Anesthesiol; 2021 Jan; 21(1):26. PubMed ID: 33482737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
